It was a mixed close for the markets with the Dow retreating 21 points to 20,881 as crude oil prices slipped. Nasdaq gained 14 points to 5,875.
On the upside
Shares of Cerulean Pharma (Nasdaq: CERU) surged on no news.
Aurinia Pharmaceuticals (Nasdaq: AUPH) announced a public offering of common stock.
Calithera Biosciences (Nasdaq: CALA) will report fourth quarter and full year results on Thursday, March 16, 2017.
On the downside
Blackstone (NYSE: BX) will sell 49% of its holdings in NCR (NYSE: NCR) back to NCR. NCR also cut its full year and first quarter earnings outlook.
Osiris Therapeutics (Nasdaq: OSIR) received a delisting notice from the NASDAQ Stock Market and announced that trading on the common stock will be suspended at market open on Tuesday, March 14, 2017.
ParkerVision (Nasdaq: PRKR) will file a motion to terminate its ITC investigation.
In the broad market, advancing issues outpaced decliners by a margin of nearly 3 to 2 on the NYSE and by nearly 5 to 3 on Nasdaq. The broader S&P 500 index edged up a fraction to 2,373. Bitcoin climbed $17 to $1,233.
